Serological Evidence of Widespread Zika Transmission across the Philippines.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
23 07 2021
Historique:
received: 29 06 2021
revised: 15 07 2021
accepted: 20 07 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 4 2 2022
Statut: epublish

Résumé

Zika virus (ZIKV) exposure across flavivirus-endemic countries, including the Philippines, remains largely unknown despite sporadic case reporting and environmental suitability for transmission. Using laboratory surveillance data from 2016, 997 serum samples were randomly selected from suspected dengue (DENV) case reports across the Philippines and assayed for serological markers of short-term (IgM) and long-term (IgG) ZIKV exposure. Using mixture models, we re-evaluated ZIKV IgM/G seroprevalence thresholds and used catalytic models to quantify the force of infection (attack rate, AR) from age-accumulated ZIKV exposure. While we observed extensive ZIKV/DENV IgG cross-reactivity, not all individuals with active DENV presented with elevated ZIKV IgG, and a proportion of dengue-negative cases (DENV IgG-) were ZIKV IgG-positive (14.3%, 9/63). We identified evidence of long-term, yet not short-term, ZIKV exposure across Philippine regions (ZIKV IgG+: 31.5%, 314/997) which was geographically uncorrelated with DENV exposure. In contrast to the DENV AR (12.7% (95%CI: 9.1-17.4%)), the ZIKV AR was lower (5.7% (95%CI: 3-11%)) across the country. Our results provide evidence of widespread ZIKV exposure across the Philippines and suggest the need for studies to identify ZIKV infection risk factors over time to better prepare for potential future outbreaks.

Identifiants

pubmed: 34452307
pii: v13081441
doi: 10.3390/v13081441
pmc: PMC8402696
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
Immunoglobulin M 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 206250/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V031112/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206471/Z/17/Z
Pays : United Kingdom

Références

Sci Rep. 2017 Sep 5;7(1):10498
pubmed: 28874759
BMC Infect Dis. 2018 Jul 4;18(1):301
pubmed: 29973158
Emerg Infect Dis. 2020 Sep;26(9):2300-2301
pubmed: 32818418
Diagnostics (Basel). 2020 Jun 04;10(6):
pubmed: 32512812
Lancet Infect Dis. 2019 Apr;19(4):439-446
pubmed: 30826189
Euro Surveill. 2016 Apr 21;21(16):
pubmed: 27126052
Diagn Microbiol Infect Dis. 2018 Jan;90(1):26-30
pubmed: 29107414
Lancet Infect Dis. 2020 Dec;20(12):1446-1456
pubmed: 32673593
PLoS Med. 2019 Mar 5;16(3):e1002755
pubmed: 30835728
Virol J. 2018 Jul 13;15(1):108
pubmed: 30005683
Lancet Infect Dis. 2017 Aug;17(8):813-821
pubmed: 28527892
J Immunol Res. 2015;2015:738030
pubmed: 26770994
Elife. 2020 Jan 28;9:
pubmed: 31987069
Euro Surveill. 2016 Dec 15;21(50):
pubmed: 28006649
Nat Commun. 2021 Mar 15;12(1):1671
pubmed: 33723237
Lancet. 2016 Apr 9;387(10027):1531-1539
pubmed: 26948433
Elife. 2019 May 23;8:
pubmed: 31120419
Science. 2019 Feb 8;363(6427):607-610
pubmed: 30733412
Emerg Microbes Infect. 2018 Jul 13;7(1):130
pubmed: 30006514
Lancet Glob Health. 2018 May;6(5):e494
pubmed: 29653619
J Clin Microbiol. 2005 Oct;43(10):4977-83
pubmed: 16207951
Elife. 2019 Apr 08;8:
pubmed: 30958263
PLoS One. 2010 Aug 23;5(8):e12347
pubmed: 20808806
Science. 2016 Aug 12;353(6300):aaf8160
pubmed: 27417495
BMC Med. 2020 Nov 27;18(1):364
pubmed: 33243267
Curr Opin Immunol. 2017 Oct;48:1-6
pubmed: 28738211
PLoS Negl Trop Dis. 2021 Apr 19;15(4):e0009336
pubmed: 33872309
Front Cell Infect Microbiol. 2018 Feb 15;8:44
pubmed: 29497604
Microbiol Spectr. 2014 Dec;2(6):
pubmed: 26104444
Int J Environ Res Public Health. 2018 Jan 09;15(1):
pubmed: 29315224
Emerg Infect Dis. 2015 Apr;21(4):722-4
pubmed: 25811410
Elife. 2018 Aug 14;7:
pubmed: 30103854
Nat Rev Immunol. 2019 Apr;19(4):218-230
pubmed: 30679808
Science. 2020 Aug 28;369(6507):1123-1128
pubmed: 32855339

Auteurs

Joseph R Biggs (JR)

Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Ava Kristy Sy (AK)

Department of Virology, Research Institute for Tropical Medicine, Manila 1781, Philippines.
Dengue Study Group, Research Institute for Tropical Medicine, Manila 1781, Philippines.

Oliver J Brady (OJ)

Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Adam J Kucharski (AJ)

Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Sebastian Funk (S)

Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Yun-Hung Tu (YH)

Department of Molecular Parasitology and Tropical Diseases, Graduate Institute of Medical Sciences, Taipei Medical University, Taipei 11031, Taiwan.

Mary Anne Joy Reyes (MAJ)

Department of Virology, Research Institute for Tropical Medicine, Manila 1781, Philippines.
Dengue Study Group, Research Institute for Tropical Medicine, Manila 1781, Philippines.

Mary Ann Quinones (MA)

Department of Virology, Research Institute for Tropical Medicine, Manila 1781, Philippines.
Dengue Study Group, Research Institute for Tropical Medicine, Manila 1781, Philippines.

William Jones-Warner (W)

Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

James Ashall (J)

Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Ferchito L Avelino (FL)

Department of Health, Philippine Epidemiology Bureau, Manila 1003, Philippines.

Nemia L Sucaldito (NL)

Department of Health, Philippine Epidemiology Bureau, Manila 1003, Philippines.

Amado O Tandoc (AO)

Department of Virology, Research Institute for Tropical Medicine, Manila 1781, Philippines.

Eva Cutiongco-de la Paz (E)

Institute of Human Genetics, University of the Philippines, Manila 1000, Philippines.
Philippine Genome Centre, University of the Philippines, Manila 1101, Philippines.

Maria Rosario Z Capeding (MRZ)

Dengue Study Group, Research Institute for Tropical Medicine, Manila 1781, Philippines.
Institute of Human Genetics, University of the Philippines, Manila 1000, Philippines.

Carmencita D Padilla (CD)

Institute of Human Genetics, University of the Philippines, Manila 1000, Philippines.
Philippine Genome Centre, University of the Philippines, Manila 1101, Philippines.

Martin L Hibberd (ML)

Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Institute of Human Genetics, University of the Philippines, Manila 1000, Philippines.
Philippine Genome Centre, University of the Philippines, Manila 1101, Philippines.

Julius Clemence R Hafalla (JCR)

Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH